Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2014

Dec 23, 2014

34999_dirs_2014-12-23_fccd1eb9-6e8f-4ab1-8921-b5efaf287e90.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2014-12-20

Reporting Person: CUDDIHY ROBERT V JR (COO/CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-20 Option (right to buy) $1.39 A 40000 Acquired 2021-12-18 Common Stock (40000) Direct

Footnotes

F1: The transaction reported in the row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that is immediately vested as of the date of grant, as detailed in a stock option award agreement between the Issuer and the Reporting Person, dated as of December 20, 2014.